Insider buying
~$2.1K2,500 sh @ $0.8498
First insider buy since Aug 2025Traded Nov 16 · filed 1 day later
Since the trade −8.5% · S&P 500 −1.0% · to Nov 17
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ICU · NASDAQ · Surgical & Medical Instruments & Apparatus
Seastar Medical Holding (ICU) · oqro.io/stocks/ICU · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.781−0.0725 (−8.49%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
−74.2% (−$2.25) from Nov 17, 2025 to Nov 17, 2026 · adjusted daily closes
Adjusted close went from $3.03 on Nov 17, 2025 to $0.781 on Nov 17, 2026 (−74.2%). Disclosed in this range: 2 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Surgical & Medical Instruments & Apparatus company based in Denver, Co.
Last 12 months
−74.2%
Market value
$4.15M
S&P 500 +10.0% over the same dates. Prices adjusted for splits and dividends.
Short interest: 175K shares sold short (3.3% of shares outstanding), −5.7% vs the previous count, 1.3 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$635K
+247.0% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $6.3M, at Jun 30, 2025
Net income, last 12 months
−$14.7M
Operating profit covers interest -516.9x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 12, 2026.
Revenue, fiscal 2025
$1.23M
+814.1% vs the year before
Net income, fiscal 2025
−$12.2M
A loss for the year
Shares outstanding
5.32M
As of Nov 1, 2026
Insider buying
First insider buy since Aug 2025Traded Nov 16 · filed 1 day later
Since the trade −8.5% · S&P 500 −1.0% · to Nov 17
Yes. Insiders of Seastar Medical Holding (ICU) filed 2 open-market purchases in the last 90 days; the latest was filed on Nov 17, 2026.
Since 2022, Seastar Medical Holding insiders reported 21 open-market purchases and 0 sales on Forms 4 and 5, with purchases in 5 different years, most recently 2026.
No open-market sale by an insider of Seastar Medical Holding (ICU) was filed with the SEC in the last 90 days.
No trade in Seastar Medical Holding (ICU) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
Insider buying
First insider buy since Aug 2025Traded Nov 16 · filed 1 day later
Since the trade −8.5% · S&P 500 −1.0% · to Nov 17
Seastar Medical's Chief Medical Officer paid $6.6K out of pocket for Seastar Medical shares. 1 other person at Seastar Medical bought some too, in the same month. It was the first purchase in 15 months.
Traded Aug 26 – Aug 27, 2025 · largest single transaction ~$22K
Aug 26, 2025~$22K · 25K sh @ $0.8899
DetailsOfficial recordAug 27, 2025~$8.6K · 10K sh @ $0.8565
DetailsOfficial recordInsider buying
Traded Aug 22, 2025 · filed 3 days later
Since the trade −90.2% · S&P 500 +13.5% · to Nov 17
Seastar Medical's Chief Medical Officer paid $8K out of pocket for Seastar Medical shares. 1 other person at Seastar Medical bought some too, in the same month. Shares held went up 21% with this purchase.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last results
Nov 12, 2026
Within the 30 days after it, until Dec 12, 2026
Next results, expected
Not announced
Purchases after results
73%
16 of 22 insider purchases since 2023 came within 30 days after a results announcement
From Seastar Medical Holding's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Seastar Medical Holding's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Insiders of Seastar Medical Holding reported 21 open-market purchases and 0 sales since 2022; purchases in 5 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $8.7K2×2 trades | — |
| 2025 | $76K7×7 trades | — |
| 2024 | $29K2×2 trades | — |
| 2023 | $61K7×7 trades | — |
| 2022 | $7K3×3 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.